{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:24:03Z","timestamp":1790864643737,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4699,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/modpathol.2009.173","type":"journal-article","created":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T12:14:35Z","timestamp":1262952875000},"page":"420-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes"],"prefix":"10.1016","volume":"23","author":[{"given":"Ryan A","family":"Metcalf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Shun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Galperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena M","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidore S","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.173_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2009.173_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2004.08.002","article-title":"Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6","volume":"118","author":"Malumbres","year":"2004","journal-title":"Cell"},{"key":"10.1038\/modpathol.2009.173_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","article-title":"G1 phase progression: cycling on cue","volume":"79","author":"Sherr","year":"1994","journal-title":"Cell"},{"key":"10.1038\/modpathol.2009.173_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.leu.2401485","article-title":"Selective usage of D-type cyclins in lymphoid malignancies","volume":"13","author":"Suzuki","year":"1999","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2009.173_bib5","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","article-title":"PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma","volume":"88","author":"Rosenberg","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.173_bib6","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1038\/modpathol.2009.173_bib7","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"10.1038\/modpathol.2009.173_bib8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2006-01-0015","article-title":"A chromosomal translocation in cyclin D1-negative\/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus","volume":"108","author":"Gesk","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.2009.173_bib9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2007-10-120824","article-title":"Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression","volume":"111","author":"Herens","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2009.173_bib10","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2009.173_bib11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2009.173_bib12","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1182\/blood-2008-02-136374","article-title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"111","author":"Malumbres","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2009.173_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/modpathol.3800434","article-title":"Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma","volume":"18","author":"Hans","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.173_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1309\/8KF0-0Y0C-2F4L-UHXL","article-title":"Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features","volume":"115","author":"Moller","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2009.173_bib15","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2004-08-3112","article-title":"Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation","volume":"105","author":"Natkunam","year":"2005","journal-title":"Blood"},{"key":"10.1038\/modpathol.2009.173_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/modpathol.3880373","article-title":"Analysis of MUM1\/IRF4 protein expression using tissue microarrays and immunohistochemistry","volume":"14","author":"Natkunam","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.173_bib17","doi-asserted-by":"crossref","first-page":"D871","DOI":"10.1093\/nar\/gkm861","article-title":"The stanford tissue microarray database","volume":"36","author":"Marinelli","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/modpathol.2009.173_bib18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","article-title":"The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"},{"key":"10.1038\/modpathol.2009.173_bib19","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.4049\/jimmunol.168.5.2101","article-title":"Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development","volume":"168","author":"Su","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2009.173_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/intimm\/12.5.631","article-title":"Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development","volume":"12","author":"Solvason","year":"2000","journal-title":"Int Immunol"},{"key":"10.1038\/modpathol.2009.173_bib21","first-page":"535","article-title":"Critical role for cyclin D2 in BCR\/ABL-induced proliferation of hematopoietic cells","volume":"62","author":"Jena","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.173_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1038\/modpathol.2009.173_bib23","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/leu.2008.213","article-title":"Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2","volume":"22","author":"Klier","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2009.173_bib24","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.4049\/jimmunol.173.5.2901","article-title":"Regulation and function of cyclin D2 in B lymphocyte subsets","volume":"173","author":"Chiles","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2009.173_bib25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","article-title":"A subset of CD5\u2212 diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus","volume":"129","author":"Ehinger","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2009.173_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2559.2008.03042.x","article-title":"Cyclin D1-positive diffuse large B-cell lymphoma","volume":"52","author":"Rodriguez-Justo","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2009.173_bib27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.pas.0000172191.87176.3b","article-title":"Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features","volume":"29","author":"Wang","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.173_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","article-title":"Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas","volume":"36","author":"Thompson","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2009.173_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.173_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<543::AID-IJC7>3.0.CO;2-3","article-title":"Expression of cyclin D2 and D3 in lymphoid lesions","volume":"81","author":"Teramoto","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2009.173_bib31","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.173_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2009.173_bib33","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab\u2013CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.173_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009173","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222027521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222027521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:02:29Z","timestamp":1760230949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222027521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0893395222027521"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.173","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}